GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » PanGenomic Health Inc (XCNQ:NARA) » Definitions » EBITDA Margin %

PanGenomic Health (XCNQ:NARA) EBITDA Margin % : 0.00% (As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is PanGenomic Health EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PanGenomic Health's EBITDA for the three months ended in Sep. 2024 was C$-0.20 Mil. PanGenomic Health's Revenue for the three months ended in Sep. 2024 was C$0.00 Mil. Therefore, PanGenomic Health's EBITDA margin for the quarter that ended in Sep. 2024 was 0.00%.


PanGenomic Health EBITDA Margin % Historical Data

The historical data trend for PanGenomic Health's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PanGenomic Health EBITDA Margin % Chart

PanGenomic Health Annual Data
Trend Dec21 Dec22 Dec23
EBITDA Margin %
- - -

PanGenomic Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of PanGenomic Health's EBITDA Margin %

For the Health Information Services subindustry, PanGenomic Health's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PanGenomic Health's EBITDA Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, PanGenomic Health's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PanGenomic Health's EBITDA Margin % falls into.



PanGenomic Health EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PanGenomic Health's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-2.916/0
= %

PanGenomic Health's EBITDA Margin % for the quarter that ended in Sep. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2024 )/Revenue (Q: Sep. 2024 )
=-0.195/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PanGenomic Health  (XCNQ:NARA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


PanGenomic Health EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of PanGenomic Health's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


PanGenomic Health Business Description

Traded in Other Exchanges
Address
3800 Wesbrook Mall, Suite 102, Vancouver, BC, CAN, V6S 2L9
PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. The company's mobile app, the Nara App, provides consumers with a knowledge base tailored to an individual's user profile, developed by tracking a user's treatment regimen and their specific genomic, proteomics, and microbiome data. The Company's mission is to promote and improve the health and wellness of people and society by providing a technology platform that identifies plant-based solutions tailored to the health profile of each individual.
Executives
Kaidong Zhang Senior Officer
Vincent Lum Director, Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6), Senior Officer

PanGenomic Health Headlines

No Headlines